Assessing medical efficacy:a neglected administrative necessity.
Administrators must balance time, cost, benefits, and safety against technological innovations when assessing medical efficacy, a task requiring assertiveness, well-chosen priorities, and familiarity with patient care.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003657:Decision Making; D004344:Drug Incompatibility; D004358:Drug Therapy / Q000191:economics; D006295:Health Resources / Q000600:supply & distribution; D006739:Hospital Administration; D006801:Humans; D007349:Insurance, Health, Reimbursement; D013673:Technology Assessment, Biomedical; D013675:Technology, High-Cost; D014481:United States; D014918:Wills / Q000331:legislation & jurisprudence
D000970:Antineoplastic Agents